Pharmacovigilance, traceability and building trust in biosimilar medicines

21 December 2017

Manufacturing cost transparency could combat pricing criticism, says expert

2 November 2017

European report calms common concerns

15 September 2017

Europäer zahlen zu viel für Pillen

18 July 2017

“É possível fazer os médicos portugueses prescreverem mais genéricos”

18 July 2017

Jacek Glinka: “Biossimilares podem poupar ao SNS 120 milhões de euros”

18 July 2017

Pharma expert: EU drug agency should be ‘easily’ accessible to all

18 July 2017

Biosimilars at work: Access. Experience. Science.

1 April 2017

Biosimilar medicines are a part of today’s therapeutic armamentarium – […]

Access to Medicines at Sustainable Price: Pharma Industry and Governments Transforming Challenges into Opportunities

23 March 2017

Biosimilar interchangeability: Do you know your switching from your substitution?

21 March 2017

US FDA interchangeability guidance adds another level of confusion over […]